NCT00204607View on ClinicalTrials.gov

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

January 31, 2007

Conditions
Malignant Melanoma
Interventions
BIOLOGICAL

mRNA

DRUG

GM-CSF s.c.

Trial Locations (1)

72076

Department of Dermatology, University of Tübingen, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT00204607 - Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients | Biotech Hunter | Biotech Hunter